Status: current, Defined. Date: 31-Dec 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3161571000168116 | bictegravir + emtricitabine + tenofovir alafenamide (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3161581000168118 | bictegravir + emtricitabine + tenofovir alafenamide | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| bictegravir + emtricitabine + tenofovir alafenamide | Is a | emtricitabine + tenofovir alafenamide | true | Inferred relationship | Some | ||
| bictegravir + emtricitabine + tenofovir alafenamide | has intended active ingredient | bictegravir | true | Inferred relationship | Some | 2 | |
| bictegravir + emtricitabine + tenofovir alafenamide | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 3 | |
| bictegravir + emtricitabine + tenofovir alafenamide | has intended active ingredient | tenofovir alafenamide | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| bictegravir 50 mg + emtricitabine 200 mg + tenofovir alafenamide 25 mg tablet | Is a | True | bictegravir + emtricitabine + tenofovir alafenamide | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR